Інформація опублікована з довідковою метою і не є рекламою, офертою, публічною пропозицією або керівництвом до застосування. Представлена виключно для інформування наших пацієнтів, які перебувають за кордоном. Сайт не здійснює жодної дистанційної торгівлі. Продаж, розповсюдження, доставка та призначення товарів через веб-ресурс не провадяться. Застосування товарів та медичних послуг можливе виключно за призначенням лікаря. Консультації надаються фахівцями клініки у очному форматі або за допомогою дистанційної медичної консультації у рамках чинного законодавства. Прошу звернути Вашу увагу, що у цьому довіднику продаж товарів програмно не передбачено.
Research on geomostasis, коагулометрия
Hemostasis research and coagulometry at the "Genesis Dnipro" laboratory — blood clotting control and thrombosis prevention.
1. Prothrombin Index (PTI)
International Normalized Ratio (INR)
2. Activated Partial Thromboplastin Time (APTT)
3. Thrombin Time (TT)
4. Fibrinogen and others.
Coagulation tests reflect the overall state of the hemostatic system. They help determine how quickly a blood clot forms, identify coagulation disorders, and select the appropriate anticoagulant therapy. These tests are mandatory before surgeries, when planning pregnancy, and in the treatment of cardiovascular diseases.
Monitoring anticoagulant therapy (warfarin and others)
Anticoagulants (such as warfarin) affect the extrinsic/common pathway of blood coagulation. To avoid excessive bleeding or, conversely, thrombosis, it is necessary to regularly check how "thinned" the blood is. PT/PTI/INR is used for this purpose.
INR is standardized so that results from different laboratories can be compared.
Assessment of liver function
The liver synthesizes many blood clotting factors, especially those of the extrinsic pathway (factor VII and others). If liver functionality is impaired (e.g., in hepatitis, cirrhosis), PT/INR/PTI may be prolonged due to reduced synthesis.
In surgeries, especially major or high-risk ones (neck, abdominal, orthopedic surgeries, etc.), it is important to know how quickly the blood clots to assess the risk of bleeding. PT/INR, APTT, sometimes TT, and other indicators are used.
International Normalized Ratio (INR)
2. Activated Partial Thromboplastin Time (APTT)
3. Thrombin Time (TT)
4. Fibrinogen and others.
Coagulation tests reflect the overall state of the hemostatic system. They help determine how quickly a blood clot forms, identify coagulation disorders, and select the appropriate anticoagulant therapy. These tests are mandatory before surgeries, when planning pregnancy, and in the treatment of cardiovascular diseases.
Monitoring anticoagulant therapy (warfarin and others)
Anticoagulants (such as warfarin) affect the extrinsic/common pathway of blood coagulation. To avoid excessive bleeding or, conversely, thrombosis, it is necessary to regularly check how "thinned" the blood is. PT/PTI/INR is used for this purpose.
INR is standardized so that results from different laboratories can be compared.
Assessment of liver function
The liver synthesizes many blood clotting factors, especially those of the extrinsic pathway (factor VII and others). If liver functionality is impaired (e.g., in hepatitis, cirrhosis), PT/INR/PTI may be prolonged due to reduced synthesis.
In surgeries, especially major or high-risk ones (neck, abdominal, orthopedic surgeries, etc.), it is important to know how quickly the blood clots to assess the risk of bleeding. PT/INR, APTT, sometimes TT, and other indicators are used.
